Clinical applications of molecular biomarkers in prostate cancer detection.

Revista medico-chirurgicalǎ̌ a Societǎ̌ţii de Medici ş̧i Naturaliş̧ti din Iaş̧i

Volumn 114, Issue 2, 2010, Pages 470-475

  Dumache, Raluca ^a   Miclea, F ^b   Bumblacila B ^b   Puiu, Maria ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ALPHA-METHYLACYL-COA RACEMASE; AUTOANTIBODY; GLUTATHIONE TRANSFERASE P1; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; INTERLEUKIN 6 RECEPTOR; ISOMERASE; KALLIKREIN; PROSTATE CANCER ANTIGEN 3, HUMAN; PROSTATE SPECIFIC ANTIGEN; RASSF1 PROTEIN, HUMAN; SERINE PROTEINASE; SOMATOMEDIN BINDING PROTEIN; TMPRSS2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BLOOD; DISEASE COURSE; EARLY DIAGNOSIS; GENETICS; HUMAN; MALE; PREDICTION AND FORECASTING; PROSTATE HYPERTROPHY; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY;

ANNEXIN A3; ANTIGENS, NEOPLASM; AUTOANTIBODIES; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; GLUTATHIONE S-TRANSFERASE PI; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; KALLIKREINS; MALE; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; RECEPTORS, INTERLEUKIN-6; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 77957323098     PISSN: 03008738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)